Our studies, however, do not contest the possible role of Tex14 in mediating REST turnover; the formation of an STP complex; or the possibility of SCYL1, Tex14, PLK1, and REST being aberrantly expressed in triple-negative breast cancer cells [7]. This evidence concerns the gene SCYL1 and triple-negative breast carcinoma.